Adam E. Mullick

机构：Ionis Pharmaceuticals (United States), Kardigan · ORCID：0000-0003-4600-961X

发表论文 154 篇 · 总被引 5915 次 · h-index 35

代表论文

Apolipoprotein C3 induces inflammasome activation only in its delipidated form (2023 · Nature Immunology · 被引 25)
Blood Levels of Angiotensinogen and Hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA) (2023 · Journal of the American College of Cardiology · 被引 24)
Inhibition of the Renin-Angiotensin System Fails to Suppress β-Aminopropionitrile–Induced Thoracic Aortopathy in Mice—Brief Report (2022 · Arteriosclerosis Thrombosis and Vascular Biology · 被引 22)
Antisense Oligonucleotide Therapy for Calmodulinopathy (2024 · Circulation · 被引 20)
LRP1 protects against excessive superior mesenteric artery remodeling by modulating angiotensin II–mediated signaling (2022 · JCI Insight · 被引 15)
Mechanical regulation of macrophage metabolism by allograft inflammatory factor 1 leads to adverse remodeling after cardiac injury (2025 · Nature Cardiovascular Research · 被引 14)